A study found that states that had legalized cannabis were less likely to experience growth in vaping related lung injuries in the past year in comparison to states that prohibited marijuana use.
The study strengthened the arguments of advocates that called for marijuana reform, stating that its legalization and regulation reduced the potential risk of consumers using possibly dangerous and contaminated products.
The study also established that adult vaping rates and marijuana use rates had not increased as had been previously predicted.
It was noted that some of the teen consumers of adult-use marijuana users were ranked among the lowest with regard to lung related injuries from vaping, with less than 1 in 100,000 cases between the ages of 12-64.
On average, the frequency of these cases per state in terms of lung injuries was 1.4cases per 100,000 individuals in the said age group. In comparison, no state with high cases in lung injuries have recreation cannabis markets established.
The study indicates a negative relationship linked to EVALI (dangerous, lung disease associated with vaping) popularity and pre-outbreak vaping rates and cannabis use while also showing that well-established cannabis markets may have ejected the use of informally sourced, riskier e-liquids.
Combined, the five states that have legalized recreational cannabis i.e. Oregon, Alaska, Colorado, California and Washington, had less than one EVALI case per 100,000 residents aged between 12 and 64 while the states with the highest EVALI cases such as Minnesota, Utah, North Dakota, Indiana and Delaware, still prohibit recreation cannabis use.
It is speculated that a ban on smokeable marijuana products in two of the states mentioned above with a lot of cases, only permitted medical cannabis use. This may have further contributed to lung injuries as the only options left to consumers in the market were in the illicit and unregulated vaping market.
The CDC has in total, identified 68 deaths and over 2,800 cases linked to contaminated vape products. The agency has also discovered vitamin E acetate that is added to the illegally purchased and altered THC e-liquid cartridges as being a strong factor that may have led to the series of vaping-related lung injuries.
Another study that was published in April also ascertained that individuals living in states where recreational cannabis was legal were less than likely to sustain vaping-related lung injuries as compared to those living in states where marijuana is still illegal.
A high ranking CDC official stated last year that a clash between federal and state cannabis laws impeded research that was to aid in tackling EVALI cases.
Experts say this research shows that industry actors like Sugarmade, Inc. (OTCQB: SGMD) have a case when they say legalizing marijuana reduces some of the health risks resulting from consuming unregulated products.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.